2004 - 2005 Publications    

hemical-based translational induction of luciferase expression: an efficient tool for in vivo screening of protein farnesylation inhibitors.

Mol Pharmacol. 2005, 67:1829-33. PMID: 15784845
 
Boijoux O ¹, Boutonnet C ^{3, 4}, Giamarchi C ², Favre G ², Vagner S ³ and Faye JC ¹.

¹ INSERM U563, Centre de Physiopathologie Toulouse Purpan, Toulouse, France
² Institut Claudius Regaud Toulouse, Université Paul Sabatier, Toulouse, France
³ INSERM U 589, Centre Hospitalier Universitaire Rangueil, Toulouse, France
⁴ MilleGen SA, Labège, France

---

Technologies of human recombinant antibodies.
 
Biofutur 2005, 258:34-40.
 
Mondon P, Dubreuil O, Bouayadi K and Kharrat H.
 
MilleGen SA, Immeuble Biostep-Bat A, rue Pierre et Marie Curie, BP 38183, 31681 Labège cedex, France

---

Pharmacological-based translational induction of transgene expression in mammalian cells.
 
EMBO Rep. 2004, 5:721-7. PMID: 15192697
 
Boutonnet C ^1,2, Boijoux O ³, Bernat S ², Kharrat A ², Favre G ³, Faye JC ³, Vagner S ¹.

¹INSERM U589, Institut Louis Bugnard, CHU Rangueil Toulouse, France
²MILLEGEN SA, Labège, France
³INSERM U563, Centre Claudius Régaud, Toulouse, France

---

Hyperglycemia upregulates translation of the fibroblast growth factor 2 mRNA in mouse aorta via internal ribosome entry site.
 
FASEB J. 2004, 18:1583-5. PMID: 15289445
 
Teshima-Kondo S, † Kondo K, † Prado-Lourenco L, *,‡ Gonzalez-Herrera IG, * Rokutan K, † Bayard F, Arnal JF * and Prats AC *.
 
*INSERM U589, Institut Louis Bugnard, IFR31, CHU Rangueil, Toulouse, France
†Department of Stress Science, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima 770-8503, Japan
‡ MILLEGEN SA, Labège, France